SLS
SELLAS Life Sciences Group, Inc. Common StockstockNASDAQ
At CloseNov 13, 2026 4:00:00 PM EST
7.87USD-1.993%(-0.16)11,170,073
Pre-marketNov 13, 2026 9:29:30 AM EST
8.66USD+7.846%(+0.63)
After-hoursNov 13, 2026 4:58:30 PM EST
7.89USD+0.254%(+0.02)
SLS Financials
In Q3 FY 2026 (ended ), SELLAS Life Sciences Group, Inc. Common Stock (SLS) reported revenue of $0, net income of −$10.09M, operating cash flow of −$5.94M, and assets of $141.09M (filed ).
Loading financial statements…